Call For Papers
The IMA-I aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Immunology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Innovations in immunotherapy techniques
- Combination therapies in cancer treatment
- Mechanisms of immune evasion by tumors
- Role of the tumor microenvironment
- Personalized approaches to immunotherapy
- Adverse effects of immunotherapeutic agents
- Immunotherapy for hematological malignancies
- Emerging targets in cancer immunotherapy
- Clinical trials in immunotherapy research
- Long-term effects of immunotherapy
- Patient selection for immunotherapy
- Immunotherapy in solid tumors
- Regulatory considerations for new therapies
- Ethical issues in cancer immunotherapy
- Role of biomarkers in treatment response
- Innovative delivery methods for therapies
- Impact of lifestyle on immunotherapy outcomes
- Future of immunotherapy in oncology
- Collaboration between research and industry
- Global access to immunotherapy treatments
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.